BusinessGeneral NewsHealthcareIndustryInternational
Trending

Global head and neck cancer drug market to Set Remarkable Growth in Coming Years | AstraZeneca, Immutep, Fortress Biotech, Roche, Pfizer

Global head and neck cancer drug market

The key factors added in this report will help leading players modify their manufacturing and marketing strategies to maximize their business growth in the coming years. Major competitors along with innovative analysis of their current developments, core competencies, product portfolio and investments in each segment are highlighted in the report. On the basis of the application type and geography, the head and neck cancer drug report splits the market size by volume and value. This report also considers the changes and advancements taking place in the global market. This research report will give clear idea to readers about the overall market scenario to further decide on this market project.

Global head and neck cancer drug market is rise gradually to an estimated value of USD 2.59 Billion by 2026 registering a CAGR of 8.1% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of patients.

Interested in this report? Get an Exclusive Sample Report Now https://databridgemarketresearch.com/request-a-sample/?dbmr=global-head-and-neck-cancer-drug-market

According to the published article in American Society of Clinical Oncology in Jan 2019, it is identified that there are 65,410 cases of head and neck cancer, of which 48,000 are men and 17,410 are women. It is estimated that 14,620 patients will be dying from this disease in the current year. This significant rise in patient number acts as a driver for the growth of head and cancer drugs.

Leading major competitors currently working in the Head and neck cancer drug Cancer market are AstraZeneca Plc , Immutep, Fortress Biotech, F. Hoffmann-La Roche Ltd, Pfizer Inc., Merck KGaA,  Bristol-Myers Squibb Company, Novartis AG,  Merck & Co., Inc., Eli Lilly and Company, Regeneron Pharmaceuticals, Inc. and few among others.

Market Drivers

  • Increase in prevalence rate of Head and neck cancer worldwide
  • Chronic consumption of Tobacco products and alcohol
  • Rising awareness about treatment and technological advancement is driving the growth of market
  • Increase in the rate of R&D initiatives is driving Head and neck Cancer therapeutics market

Market Restraints

  • High cost involved in the treatment
  • Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market
  • Lack of awareness among the patient and physician about head and neck treatment

Key Developments in the Market:

In September 2018, Regeneron Pharmaceuticals, Inc. received FDA approval of Libtayo (cemiplimab-rwlc) for the treatment of patient with head and neck cancer or advanced squamous cell carcinoma. Libtaya is PD-1 (protein found on the body’s immune cells and some cancer cells) blocking antibody. The recommended dose of LIBTAYO is 350 mg given by intravenous infusion over 30 minutes every 3 weeks.

In April 2019, Merck & Co., Inc. got FDA expanded label approval of KEYTRUDA (pembrolizumab) for the treatment of recurrent or metastatic head and neck squamous cell carcinoma. It is given after the administration of platinum containing chemotherapy. Keytruda is anti PD-1 antibodies that act as immunomodulatory agent.

Know the answer to all your doubts of Head and neck cancer drug Market [email protected] https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-head-and-neck-cancer-drug-market

Segmentation: Global Head and Neck Cancer Drug Market

By Type

  • Laryngeal and hypopharyngeal cancer
  • Nasal cavity and paranasal sinus cancer
  • Oral and oropharyngeal cancer
  • Salivary gland cancer
  • Nasopharyngeal cancer
  • Others

By Drug Type

  • Carboplatin
  • Cisplatin
  • Docetaxel
  • Paclitaxel
  • 5-fluorouracil
  • Epirubicin
  • Immunomodulators
  • Others

By Treatment

  • Medication
  • Chemotherapy
  • Radiation therapy
  • Immunotherapy
  • Targeted Therapy
  • Surgery

By Route of administration

  • Oral
  • Injectable

By End users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Geography

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Avail 30% Instant Discount At https://www.databridgemarketresearch.com/request-a-discount/global-head-and-neck-cancer-drug-market

Market Drivers

Increase in prevalence rate of Head and neck cancer worldwide

Chronic consumption of Tobacco products and alcohol

Rising awareness about treatment and technological advancement is driving the growth of market

Increase in the rate of R&D initiatives is driving Head and neck Cancer therapeutics market

Table of Contents:

Executive Summary

Scope/opportunities of the Report

Research Methodology

Market Landscape

Pipeline Analysis

Market Sizing

Porter’s Five Forces Analysis

Market Segmentation

Customer Landscape

Regional Landscape

Business Decision Framework

Drivers And Challenges

Market Key Trends

Players Landscape

Players Analysis

Appendix

Get Detail [email protected] https://databridgemarketresearch.com/toc/?dbmr=global-head-and-neck-cancer-drug-market

Benefits of Report Purchase from Data Bridge Market Research:

Detailed Research

We provide accurate data and in-depth analysis with all-inclusive coverage.

Robust Research Methodology

Robust research methodology and data triangulation to ensure high quality report.

Analyst Support

24*7 analyst support – Pre and post purchase of the report as well as during the project tenure.

Sales Support

24*7 sales support – Hassle free delivery of the report and quick response and support by sales team.

Free Customization

20% post purchase free customization to meet your requirements.

Customer Satisfaction

We claim full customer satisfaction as our core values lie in building long term relationship.

Research Methodology: Global Head and neck cancer drug Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-head-and-neck-cancer-drug-market

The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]

Close